Oncology

Beginning with oncology, C4T is advancing multiple internal degraders towards the clinic. Our balanced approach to target different cancers maximizes patient impact across oncology.

Disease AreaDiscoveryPreclinicalClinical
Blood Cancers

Rights: Worldwide

Discovery
Preclinical
Clinical
Myeloma

Rights: Worldwide

Discovery
Preclinical
Clinical
Colorectal

Rights: Worldwide

Discovery
Preclinical
Clinical
Lung

Rights: Worldwide

Discovery
Preclinical
Clinical
Pancreatic

Rights: Worldwide

Discovery
Preclinical
Clinical
Myeloma/Lymphoma

Rights: Worldwide

Discovery
Preclinical
Clinical

In addition to a robust internal portfolio, C4T has established research and development partnerships with industry leading organizations.